Eckert & Ziegler to Recommend Dividend Payment
Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Dividend Eckert & Ziegler Increases Dividend Berlin, 20 March 2018. Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist for isotope-based applications in medicine, science and industry achieved sales of approx. 144.8 million EUR in the fiscal year 2017. As the Supervisory Board stated at its balance sheet meeting, the net profit was 14.7 million EUR or 2.78 EUR per share. The expectations for the fiscal year 2017 were met. Without discontinued operations sales achieved 138.6 million EUR, net profit 11.6 million EUR and earnings per share 2.19 EUR. At the General Shareholders' Meeting to be held on 30 May 2018, the Executive Board and the Supervisory Board will propose a dividend of 0.80 EUR per share entitled to a dividend (previous year: 0.66 EUR per share). The income statement, balance sheet and cash flow statement for the past fiscal year can be found on March 22, 2018 at https://www.ezag.com/home/investors/reports/ For enquiries please contact:
20-March-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Eckert & Ziegler Strahlen- und Medizintechnik AG |
Robert-Rössle-Str.10 | |
13125 Berlin | |
Germany | |
Phone: | 49 30 941084-138 |
Fax: | 49 30 941084-112 |
E-mail: | karolin.riehle@ezag.de |
Internet: | www.ezag.de |
ISIN: | DE0005659700 |
WKN: | 565970 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
End of Announcement | DGAP News Service |